Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A circulating microRNA signature as noninvasive diagnostic and prognostic biomarkers for nonalcoholic steatohepatitis

9 Mar 2018

Abstract excerpt

BACKGROUND: Noninvasive biomarkers are urgently needed for patients with nonalcoholic steatohepatitis (NASH) to assist in diagnosis, monitoring disease progression and assessing treatment response. Recently several exploratory studies showed that circulating level of microRNA is associated with NASH and correlated with disease severity. Although these data were encouraging, the application of circulating microRNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Liver Disease Diagnosis and Treatment
Share to Liver Diseases and Immunity
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29523084
DOI: 10.1186/s12864-018-4575-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A circulating microRNA signature as noninvasive diagnostic and prognostic biomarkers for nonalcoholic steatohepatitisPMID 29523084Read ↗

Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis.Semantic proximity Read ↗

MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectivesSemantic proximity Read ↗

Role of microRNA in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a comprehensive reviewSemantic proximity Read ↗

MicroRNAs and Nonalcoholic Steatohepatitis: A ReviewSemantic proximity Read ↗

The Nimble Stage 1 Study Validates Diagnostic Circulating Biomarkers for Nonalcoholic SteatohepatitisSemantic proximity Read ↗

MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesisSemantic proximity Read ↗

Serum levels of microRNAs can specifically predict liver injury of chronic hepatitis B.Semantic proximity Read ↗

Circulating MicroRNA‐122 and Fibrosis Stage Predict Mortality of Japanese Patients With Histopathologically Confirmed NAFLDSemantic proximity Read ↗

Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expressionSemantic proximity Read ↗

Differential expression and functions of microRNAs in liver transplantation and potential use as non-invasive biomarkersSemantic proximity Read ↗

Differential Associations of Circulating MicroRNAs With Pathogenic Factors in NAFLDSemantic proximity Read ↗

Silencing of <i>microRNA‐122</i> is an early event during hepatocarcinogenesis from non‐alcoholic steatohepatitisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.